S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Self-Made Multimillionaire Reveals the Top Secret of the Ultra-Rich (Ad)
Applied Materials stock is Ray Dalio's favorite in this new cycle
Palo Alto Networks aims at cyber security leadership
Self-Made Multimillionaire Reveals the Top Secret of the Ultra-Rich (Ad)
Spotify sounding better to analysts as company tunes into profits
3 Reasons the Capital One-Discover merger is a big deal
Massive "Lightning Line" Rollout Underway Across America… (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Bears covered shorts on this ETF, 3 stocks to pop on the shift
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Self-Made Multimillionaire Reveals the Top Secret of the Ultra-Rich (Ad)
Applied Materials stock is Ray Dalio's favorite in this new cycle
Palo Alto Networks aims at cyber security leadership
Self-Made Multimillionaire Reveals the Top Secret of the Ultra-Rich (Ad)
Spotify sounding better to analysts as company tunes into profits
3 Reasons the Capital One-Discover merger is a big deal
Massive "Lightning Line" Rollout Underway Across America… (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Bears covered shorts on this ETF, 3 stocks to pop on the shift
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Self-Made Multimillionaire Reveals the Top Secret of the Ultra-Rich (Ad)
Applied Materials stock is Ray Dalio's favorite in this new cycle
Palo Alto Networks aims at cyber security leadership
Self-Made Multimillionaire Reveals the Top Secret of the Ultra-Rich (Ad)
Spotify sounding better to analysts as company tunes into profits
3 Reasons the Capital One-Discover merger is a big deal
Massive "Lightning Line" Rollout Underway Across America… (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Bears covered shorts on this ETF, 3 stocks to pop on the shift
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Self-Made Multimillionaire Reveals the Top Secret of the Ultra-Rich (Ad)
Applied Materials stock is Ray Dalio's favorite in this new cycle
Palo Alto Networks aims at cyber security leadership
Self-Made Multimillionaire Reveals the Top Secret of the Ultra-Rich (Ad)
Spotify sounding better to analysts as company tunes into profits
3 Reasons the Capital One-Discover merger is a big deal
Massive "Lightning Line" Rollout Underway Across America… (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Bears covered shorts on this ETF, 3 stocks to pop on the shift

Moderna (MRNA) Short Interest Ratio & Short Volume

$87.59
+0.60 (+0.69%)
(As of 02/21/2024 ET)

Moderna Short Interest Data

Current Short Volume
20,880,000 shares
Previous Short Volume
23,070,000 shares
Change Vs. Previous Month
-9.49%
Dollar Volume Sold Short
$2.11 billion
Short Interest Ratio / Days to Cover
4.5
Last Record Date
January 31, 2024
Outstanding Shares
381,280,000 shares
Float Size
331,470,000 shares
Short Percent of Float
6.30%
Today's Trading Volume
3,753,972 shares
Average Trading Volume
3,330,302 shares
Today's Volume Vs. Average
113%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Moderna ?

Sign up to receive the latest short interest report for Moderna and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MRNA Short Interest Over Time

MRNA Days to Cover Over Time

MRNA Percentage of Float Shorted Over Time


Moderna Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/202420,880,000 shares $2.11 billion -9.5%6.3%4.5 $101.05
1/15/202423,070,000 shares $2.44 billion -4.6%7.0%4.5 $105.95
12/31/202324,190,000 shares $2.41 billion +10.6%7.3%4.6 $99.45
12/15/202321,880,000 shares $1.88 billion -0.5%6.6%4.7 $86.01
11/30/202321,990,000 shares $1.71 billion -1.7%6.6%5.4 $77.70
11/15/202322,380,000 shares $1.71 billion +14.1%6.8%5.6 $76.35
10/31/202319,610,000 shares $1.49 billion +8.6%5.9%4.6 $75.96
10/15/202318,050,000 shares $1.77 billion -2.3%5.5%4.5 $98.30
9/30/202318,470,000 shares $1.91 billion +1.7%5.6%4.9 $103.29
9/15/202318,160,000 shares $2.08 billion +0.6%5.5%4.8 $114.59
8/31/202318,050,000 shares $2.04 billion +4.8%5.5%5.1 $113.07
8/15/202317,220,000 shares $1.66 billion +9.2%5.2%4.6 $96.41
7/31/202315,770,000 shares $1.86 billion +1.7%4.8%4.6 $117.66
7/15/202315,510,000 shares $1.88 billion -11.7%4.7%4.8 $121.35
6/30/202317,560,000 shares $2.13 billion -4.2%5.3%5.2 $121.50
6/15/202318,320,000 shares $2.38 billion -2.1%5.5%5.5 $129.98
5/31/202318,720,000 shares $2.39 billion +2.7%5.6%5.6 $127.71
5/15/202318,220,000 shares $2.37 billion +2.1%5.5%5.1 $130.26
4/30/202317,850,000 shares $2.37 billion +6.9%5.4%5.1 $132.89
4/15/202316,700,000 shares $2.62 billion -2.6%5.0%4.7 $157.10
3/31/202317,150,000 shares $2.63 billion +7.9%5.1%4.8 $153.58
3/15/202315,890,000 shares $2.38 billion +1.3%4.7%4 $149.60
2/28/202315,680,000 shares $2.18 billion +6.9%4.7%3.2 $138.81
2/15/202314,670,000 shares $2.60 billion +3.8%4.4%3 $177.28
1/31/202314,130,000 shares $2.49 billion +0.6%4.2%2.9 $176.06
1/15/202314,040,000 shares $2.70 billion No Change4.2%2.7 $192.00
12/30/202214,040,000 shares $2.52 billion -15.8%4.2%2.6 $179.62
12/15/202216,670,000 shares $3.45 billion No Change5.0%3.1 $207.25
11/30/202216,670,000 shares $2.93 billion +4.3%5.0%3.6 $175.91
11/15/202215,980,000 shares $2.96 billion -3.0%4.8%3.3 $185.47
10/31/202216,480,000 shares $2.48 billion +2.0%5.0%3.3 $150.33
10/15/202216,160,000 shares $2.17 billion +2.2%4.8%3.3 $134.00
9/30/202215,810,000 shares $1.87 billion -3.2%4.7%3.5 $118.25
9/15/202216,340,000 shares $2.22 billion +7.4%4.9%3.3 $135.86
8/31/202215,210,000 shares $2.01 billion +1.5%4.5%3.1 $132.27
8/15/202214,980,000 shares $2.65 billion +1.7%4.4%2.9 $176.78
7/31/202214,730,000 shares $2.42 billion -9.6%4.3%2.7 $164.09
7/15/202216,290,000 shares $2.72 billion +14.3%4.8%2.9 $166.91
6/30/202214,250,000 shares $2.04 billion -3.5%4.2%2.4 $142.85
6/15/202214,760,000 shares $1.90 billion -4.9%4.3%2.4 $128.53













MRNA Short Interest - Frequently Asked Questions

What is Moderna's current short interest?

Short interest is the volume of Moderna shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 20,880,000 shares of MRNA short. 6.30% of Moderna's shares are currently sold short. Learn More on Moderna's current short interest.

What is a good short interest ratio for Moderna?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRNA shares currently have a short interest ratio of 4.0. Learn More on Moderna's short interest ratio.

Which institutional investors are shorting Moderna?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Moderna: DRW Securities LLC, GTS Securities LLC, Wolverine Trading LLC, Paloma Partners Management Co, Parallax Volatility Advisers L.P., HAP Trading LLC, Citadel Advisors LLC, Clear Street LLC, CMT Capital Markets Trading GmbH, Cubist Systematic Strategies LLC, Nomura Holdings Inc., Verition Fund Management LLC, Capital Fund Management S.A., PEAK6 Investments LLC, Goldman Sachs Group Inc., Capstone Investment Advisors LLC, Allianz Asset Management GmbH, Hsbc Holdings PLC, IMC Chicago LLC, One River Asset Management LLC, UBS Group AG, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., Warberg Asset Management LLC, CTC LLC, Simplex Trading LLC, XR Securities LLC, SpiderRock Advisors LLC, Valeo Financial Advisors LLC, Cutler Group LLC CA, SG Americas Securities LLC, One River Asset Management LLC, and Citigroup Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Moderna?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.30% of Moderna's floating shares are currently sold short.

Is Moderna's short interest increasing or decreasing?

Moderna saw a drop in short interest in January. As of January 31st, there was short interest totaling 20,880,000 shares, a drop of 9.5% from the previous total of 23,070,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Moderna's float size?

Moderna currently has issued a total of 381,280,000 shares. Some of Moderna's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Moderna currently has a public float of 331,470,000 shares.

How does Moderna's short interest compare to its competitors?

6.30% of Moderna's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Moderna: Biogen Inc. (2.12%), argenx SE (2.01%), BioNTech SE (1.27%), Neurocrine Biosciences, Inc. (1.89%), Repligen Co. (11.17%), Bio-Techne Co. (2.11%), Qiagen (1.13%), CRISPR Therapeutics AG (19.82%), Denali Therapeutics Inc. (8.99%), Gilead Sciences, Inc. (1.26%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Moderna stock?

Short selling MRNA is an investing strategy that aims to generate trading profit from Moderna as its price is falling. MRNA shares are trading up $0.60 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Moderna?

A short squeeze for Moderna occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MRNA, which in turn drives the price of the stock up even further.

How often is Moderna's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRNA, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:MRNA) was last updated on 2/22/2024 by MarketBeat.com Staff